0.008
0.00 (14.29%)
Previous Close | 0.007 |
Open | 0.008 |
Volume | 36,927,722 |
Avg. Volume (3M) | 30,542,295 |
Market Cap | 51,292,004 |
Price / Sales | 735.64 |
Price / Book | 13.69 |
52 Weeks Range | |
Earnings Date | 28 Feb 2025 |
Operating Margin (TTM) | -469.68% |
Diluted EPS (TTM) | 0.000 |
Quarterly Revenue Growth (YOY) | -15.50% |
Total Debt/Equity (MRQ) | 1.36% |
Current Ratio (MRQ) | 3.84 |
Operating Cash Flow (TTM) | -16.47 M |
Levered Free Cash Flow (TTM) | -8.87 M |
Return on Assets (TTM) | -78.37% |
Return on Equity (TTM) | -155.77% |
Market Trend
Short Term | Medium Term | ||
Industry | Biotechnology (AU) | Mixed | Mixed |
Biotechnology (Global) | Mixed | Bearish | |
Stock | ALTERITY FPO [ATH] | - | - |
AIStockmoo Score
Analyst Consensus | 0.0 |
Insider Activity | NA |
Price Volatility | -2.0 |
Technical Moving Averages | 2.5 |
Technical Oscillators | 4.0 |
Average | 1.13 |
Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders. |
|
Sector | Healthcare |
Industry | Biotechnology |
Investment Style | Small Value |
% Held by Insiders | 6.10% |
% Held by Institutions | 13.83% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |